We are live on
!
Find out more
KXA
KPCB XIV Associates Portfolio holdings
AUM
$42.8M
1-Year Est. Return
16.52%
This Fund
S&P 500
This Quarter
Est. Return
-46.73%
1 Year Est. Return
-16.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$267M
AUM Growth
–
Cap. Flow
+$324M
Cap. Flow
% of AUM
121.39%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Beyond Meat
BYND
|
+$317M |
| 2 |
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
|
+$6.46M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 96.96% |
| 2 | Healthcare | 3.04% |
Similar funds
SIP
AMC
OMC
JMF
MAM
HCM
MCAV
ZAM
KPCB XIV Associates's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for KPCB XIV Associates, which disclosed 2 positions worth $267M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Beyond Meat: 3,419,321 shares worth $259M.
By sector, the portfolio is most concentrated in Consumer Staples at 97% of assets, followed by Healthcare.
- KPCB XIV Associates's largest Q4 2019 buy was Beyond Meat: 3,419,321 shares worth $259M.
- KPCB XIV Associates's ten largest holdings make up 100% of its $267M portfolio in Q4 2019.
- KPCB XIV Associates disclosed 2 positions in Q4 2019, its first 13F filing on record.
Based on KPCB XIV Associates's 13F filing for Q4 2019, filed 13 Feb 2020.